SCA
BIIB icon

Sippican Capital Advisors’s Biogen BIIB Stock Holding History

Sippican Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,426
Closed -$494K – 113
2021
Q2 		$494K Buy
1,426
+75
+6% +$22.7K 0.43% 78
2021
Q1 		$378K Sell
1,351
-165
-11% -$44.5K 0.35% 81
2020
Q4 		$371K Buy
1,516
+290
+24% +$74.8K 0.4% 75
2020
Q3 		$348K Buy
1,226
+463
+61% +$129K 0.43% 72
2020
Q2 		$204K Buy
+763
New +$229K 0.28% 88

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sippican Capital Advisors's BIIB Position: Q3 2021 in Review

Sippican Capital Advisors sold out of Biogen (BIIB) in Q3 2021, closing a stake of 1,426 shares — an estimated $494K sold.

Sippican Capital Advisors first reported a position in BIIB in Q2 2020 and held it in 5 quarters. The position peaked at $494K in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Sippican Capital Advisors reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Sippican Capital Advisors sold 1,426 Biogen shares in Q3 2021, an estimated $494K.
  • Sippican Capital Advisors first reported a position in Biogen in Q2 2020 and held it in 5 quarters.
  • Sippican Capital Advisors's Biogen position peaked at $494K in Q2 2021.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Sippican Capital Advisors's 13F filing for Q3 2021, filed 20 Oct 2021.